Local infusion of infliximab for the treatment of acute joint inflammation
Open Access
- 1 August 2003
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 62 (8) , 783-784
- https://doi.org/10.1136/ard.62.8.783
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor αNew England Journal of Medicine, 2002
- Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritisArthritis & Rheumatism, 2000
- Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trialThe Lancet, 1999
- Localization of Tumor Necrosis Factor α in Synovial Tissues and at the Cartilage–Pannus Junction in Patients With Rheumatoid ArthritisArthritis & Rheumatism, 1991